Qualitative analysis of the deposit of collagen in bladder suture of rats treated with tacrolimus combined with mycophenolate-mofetil
AUTOR(ES)
Paul, Gustavo Marquesine, Tambara Filho, Renato, Repka, João Carlos Domingues
FONTE
Int. braz j urol.
DATA DE PUBLICAÇÃO
2014-04
RESUMO
PurposeTo evaluate the synthesis of type I (mature) and type III (immature) collagen in bladder suture of rats treated with a combination of tacrolimus and mycophenolate mofetil for 15 days.Materials and MethodsThirty rats were divided into 3 groups: the sham, control and experimental groups. All the animals underwent laparotomy, cystotomy and bladder suture in two planes with surgical PDS 5-0 thread. The sham group did not receive treatment. The control group received saline solution, and the experimental group received 0.1mg/kg/day of tacrolimus with 20mg/kg/day of mycophenolate mofetil, for 15 days. From then on, the tacrolimus was dosed. The surgical specimens of the bladder suture area were processed so that the total type I and type III collagen could be measured by the picrosirius red technique.ResultsThere was a predominance of type I collagen production in the sham and control groups compared to the experimental group, in which type III collagen was predominant. The production of total collagen did not change.ConclusionThe association of tacrolimus and mycophenolate mofetil in animals qualitatively changes the production of collagen after 15 days with a predominance of type III collagen.
Documentos Relacionados
- Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil
- Effects of immunosuppression with tacrolimus and mycophenolate mofetil on renal histology and function in single kidney rats submitted to ischemia and reperfusion
- Analysis of the histology of the scar bladder and biochemical parameters of rats with a solitary kidney undergoing immunosuppression with tacrolimus
- Induction of remission in active anti‐neutrophil cytoplasmic antibody‐associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide
- Mycophenolate mofetil in patients with refractory systemic autoimmune myopathies: case series